Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected5Y Return
Partial Period · Aug 29, 2022 — Aug 31, 2026
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | BIAF | PFE |
|---|---|---|---|
| Return | |||
| Last Price | — | 15.27 | 28.45 |
| Daily Change | — | + 19.48% | − 1.25% |
| Period ReturnPast 5 Years | + 118.34% | − 99.52%Aug 29, 2022 — Aug 31, 2026 | − 37.60% |
| Valuation | |||
| Market Cap | $4.50 B | $3.24 M | $162 B |
| P/E Ratio | — | — | 37.66 |
| Dividend Yield | — | — | 5.38% |
| Net MarginTrailing 12M | — | 257.3% | 6.8% |
| Risk | |||
| Beta | 0.90 | -1.36 | 0.28 |
| 52-Week Range | 41.77 — $54.83 | 4.56 — $202.50 | 23.58 — $29.21 |
| Company | |||
| Sector | — | — | Health Care |
| Industry | Biotechnology | Biotechnology | Pharmaceuticals |
Company
- AKROBiotechnology
- BIAFBiotechnology
- PFEHealth Care · Pharmaceuticals
FinnhubUpdated 23:00
To Understand This